CLINICAL_TRIALS
trial_result
· 2024-09-25
Clinical Trial Update: Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Summary
Pfizer completed a post-marketing drug-use investigation for temsirolimus in renal cell carcinoma. The trial results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Renal Cell Carcinoma | Status: COMPLETED | Results posted: 2024-09-25